The Effectiveness of a 9-Month Regimen of Isoniazid Alone versus 3- and 4-Month Regimens of Isoniazid plus Rifampin for Treatment of Latent Tuberculosis Infection in Children: Results of an 11-Year Randomized Study
Clinical Infectious Diseases2007Vol. 45(6), pp. 715–722
Citations Over TimeTop 10% of 2007 papers
Nikolaos Spyridis, Panayiotis Spyridis, A. Gelesme, Vana Sypsa, M. Valianatou, Flora Metsou, Dimitrios Gourgiotis, Μαρία Τσολιά
Abstract
Short-course treatment with isoniazid and rifampin for 3-4 months is safe and seems to be superior to a 9-month course of isoniazid monotherapy.
Related Papers
- → Low Isoniazid Concentrations and Outcome of Tuberculosis Treatment with Once-Weekly Isoniazid and Rifapentine(2003)192 cited
- → Treatment of Latent Tuberculosis Infection in HIV: Shorter or Longer?(2012)11 cited
- → Evaluation of Once-Weekly Therapy for Tuberculosis Using Isoniazid plus Rifamycins in the Mouse Aerosol Infection Model(1998)21 cited
- → Tuberculosis Prevention in HIV-Positive Adults with Latent Disease(2011)
- → The Cost-Effectiveness Of 3 Months Of Weekly, Directly-Observed Rifapentine Plus Isoniazid (3HP) Vs. 9 Months Of Daily, Self-Administered Isoniazid (9H) For The Treatment Of Latent Tuberculosis Infection(2012)